Research that creates value
The research activity of Ri.MED is strongly patient oriented, but in order to ensure that scientific results meet clinical needs, it is necessary to correctly manage the intellectual property generated by our researchers as well as the process of technology transfer which derives from it. From the laboratories, inventions are translated into patents and then into new solutions for the patients.
The protection of intellectual property is a fundamental value for Ri.MED to develop an innovative model of research sustainability. For this reason, Ri.MED has set up an IP&TT (Intellectual Property and Technology Transfer) Office to support, promote, and foster the progress of translational research through the enhancement of its application effects: patenting, patent licensing, industrial sponsorship, and creation of technological spin-offs.
Furthermore, in 2021 Ri.MED and a multinational company operating in the cardiovascular area finalized an important license and collaboration agreement having as its object the Ri.MED patent for the Triskele cardiac implant. This family of patent consists of a heart valve prosthesis, a heart valve, and a related delivery system. One of the inventors is Gaetano Burriesci, Bioengineering group leader of the Foundation.